Merit Financial Group, LLC Adma Biologics, Inc. Transaction History
Merit Financial Group, LLC
- $10.9 Billion
- Q4 2025
A detailed history of Merit Financial Group, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Merit Financial Group, LLC holds 10,594 shares of ADMA stock, worth $164,842. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,594Holding current value
$164,842% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
409Shares Held
204MCall Options Held
3.06MPut Options Held
1.88M-
Vanguard Group Inc Valley Forge, PA20.9MShares$324 Million0.0% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$290 Million0.0% of portfolio
-
State Street Corp Boston, MA13.6MShares$211 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.5MShares$195 Million0.03% of portfolio
-
Sachem Head Capital Management LP New York, NY8.96MShares$139 Million5.63% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.06B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...